Antimicrobial susceptibility in Clostridioides difficile varies according to European region and isolate source
JAC-Antimicrobial Resistance · 03.07.2024 · 6 (4)
DOI: 10.1093/jacamr/dlae112 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAC-Antimicrobial Resistance, online erschienen am 23.07.2024. Verfasst von Jane Freeman und 12 weiteren Autor:innen. Beteiligte Einrichtung: Healthcare Associated Infections Research Group, Leeds Institute of Medical Research, University of Leeds, Leeds, UK. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Innovative Medicines Initiative, European Federation of Pharmaceutical Industries and Associations.
Abstract (Originalsprache)
Objectives
Clostridioides difficile epidemiology is evolving with country-associated emerging and resistant ribotypes (RT). Antimicrobial susceptibility testing of C. difficile isolated from clinical and animal samples collected across Europe in 2018 was performed to provide antimicrobial resistance data and according to C. difficile RTs and source.
Methods
Samples were cultured for C. difficile and isolates PCR ribotyped. Metronidazole, vancomycin, fidaxomicin, moxifloxacin, clindamycin, imipenem, tigecycline, linezolid, rifampicin and meropenem minimum inhibitory concentrations (MICs) for 280 clinical and 126 animal isolates were determined by Wilkins–Chalgren agar dilution.
Results
Fidaxomicin was the most active antimicrobial (all isolates geometric mean MIC = 0.03 mg/L) with no evidence of reduced susceptibility. Metronidazole MICs were elevated among RT027 (1.87 mg/L) and RT181 clinical isolates (1.03 mg/L). RT027 and RT181 had elevated geometric mean moxifloxacin MICs (14.49 mg/L, 16.88 mg/L); clindamycin (7.5 mg/L, 9.1 mg/L) and rifampicin (0.6 mg/L, 21.5 mg/L). Five isolates (RT002, RT010 and RT016) were metronidazole resistant (MIC = 8 mg/L) and 10 (RT027; RT198) had intermediate resistance (4 mg/L). Metronidazole MICs were not elevated in animal isolates. Increased geometric mean vancomycin MICs were observed among RT078, mostly isolated from animals, but there was no resistance (MIC ≥ 4 mg/L). Clinical and animal isolates of multiple RTs showed resistance to moxifloxacin and clindamycin. No resistance to imipenem or meropenem was observed.
Conclusion
Increased antimicrobial resistance was detected in eastern Europe and mostly associated with RT027 and related emerging RT181, while clinical isolates from northern and western Europe had the lowest general levels of resistance.
Autor:innen und Institutionen
- Healthcare Associated Infections Research Group, Leeds Institute of Medical Research, University of Leeds, Leeds, UK.
- Department of Microbiology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
- European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Study Group for Clostridioides difficile (ESGCD), Basel, Switzerland.
- C. difficile Ribotyping Network for England and Wales, UK Health Security Agency, Leeds, UK.
- National Laboratory for Health, Environment and Food (NLZOH), Centre for Medical Microbiology, Maribor, Slovenia.
- Faculty of Medicine, University of Maribor, Maribor, Slovenia.
ORCID-Profile: Mark Wilcox, Kerrie Davies
Förderung
- Innovative Medicines Initiative
- European Federation of Pharmaceutical Industries and Associations
Zitieren
APA
Freeman, J., Viprey, V., Ewin, D., Spittal, W., Clark, E., Vernon, J., Fawley, W., Davis, G., Tkalec, V., Wilcox, M., Rupnik, M., Davies, K., & COMBACTE-CDI Consortium (2024). Antimicrobial susceptibility in Clostridioides difficile varies according to European region and isolate source. JAC-Antimicrobial Resistance, 6(4). https://doi.org/10.1093/jacamr/dlae112
Vancouver
Freeman J, Viprey V, Ewin D, Spittal W, Clark E, Vernon J, et al. Antimicrobial susceptibility in Clostridioides difficile varies according to European region and isolate source. JAC-Antimicrobial Resistance. 2024;6(4). doi:10.1093/jacamr/dlae112
BibTeX
@article{Freeman2024,
author = {Freeman, Jane and Viprey, Virginie and Ewin, Duncan and Spittal, William and Clark, Emma and Vernon, Jon and Fawley, Warren and Davis, Georgina and Tkalec, Valerija and Wilcox, Mark and Rupnik, Maja and Davies, Kerrie and COMBACTE-CDI Consortium, COMBACTE-CDI Consortium},
title = {Antimicrobial susceptibility in Clostridioides difficile varies according to European region and isolate source},
journal = {JAC-Antimicrobial Resistance},
year = {2024},
volume = {6},
number = {4},
doi = {10.1093/jacamr/dlae112}
}
EUVIMED